Glucose Variability, Explained

Two people can average the same glucose and live completely different days — one riding a calm, gentle line, the other lurching between spikes and dips. Glucose variability is the metric that tells those two apart. It doesn't ask where your glucose sits on average; it asks how much it moves.

What glucose variability means

Glucose variability describes how much your blood glucose swings up and down over a given period. Where an HbA1c reports a long-term average and time in range reports how much of the day you spend in a target band, variability captures the amplitude and frequency of the movement itself — the height of the peaks, the depth of the dips, and how often they happen.

It is a distinct idea from the average. You can have a healthy-looking average built from big highs and lows that cancel out, or a similar average built from a steady, narrow line. Variability is what separates those two stories.

How it's measured: the coefficient of variation

The most widely cited way to summarize variability from CGM data is the coefficient of variation (CV). In plain terms, CV expresses the size of the swings relative to the average glucose, usually as a percentage. A higher CV means wider swings for a given average; a lower CV means a steadier line.

Expert consensus commonly references a CV of 36% or lower as a threshold for relatively stable glucose, with higher values considered more variable and, in some contexts, associated with a greater chance of low glucose. A few points worth keeping in mind:

• This 36% figure is a general reference point from consensus recommendations, not a personal goal or a diagnosis.
• Other measures exist too — such as standard deviation and mean amplitude of glycemic excursions — and researchers do not fully agree on which best captures what matters.
• A number in isolation says little; context and trend matter more than a single reading.

Why the swings may matter

Here it is worth being careful. Researchers are actively studying whether glucose variability carries meaning beyond average glucose — for example whether frequent large swings relate to how people feel day to day or to longer-term outcomes. Some studies suggest associations, but the science is still evolving, and much of the strongest evidence concerns the practical link between high variability and a greater likelihood of hypoglycemia (low glucose).

What can be said with more confidence is the everyday, experiential side: large swings often track with the post-meal spikes and subsequent dips that some people notice as changes in energy or hunger. That is a reasonable, general observation — not a promise about any individual, and not a claim that reducing variability treats or prevents disease. Where the mechanism is uncertain, it is honest to say so.

How a CGM reveals it

Variability is essentially invisible to point-in-time testing. A fasting glucose or an HbA1c gives you a dot or an average; neither can show a sharp rise at 1 p.m. and a dip at 4 p.m. A continuous glucose monitor samples glucose every few minutes, so it captures those peaks and troughs directly. From that continuous trace, software can compute the coefficient of variation and display the pattern visually.

This is where variability, time in range, and the Glucose Management Indicator work together: the average tells you the general level, time in range tells you how much of the day was on target, and variability tells you how bumpy the ride was. Seeing all three is far more informative than any one alone. Related patterns like the dawn phenomenon also become visible in the same trace.

What to do with the number

If you use a CGM and see higher variability, treat it as a cue to look at when the swings happen rather than as a verdict. Patterns often cluster around particular meals, activity, sleep, or stress. Whether any change is warranted — and what it should be — is a conversation for a qualified clinician, who can interpret variability alongside your full picture rather than in isolation.

Sources

Further reading from established public sources: Battelino et al., Diabetes Care (2019) — Clinical Targets for CGM Data Interpretation · American Diabetes Association — CGM & Time in Range · NIH / NIDDK — Continuous Glucose Monitoring.

Related: What is time in range · HbA1c vs CGM · The dawn phenomenon